Anti–mPD-1H mAbs could also reduce C1498FF–mPD-1H-Δ growth in vivo, suggesting that mAbs were not affecting signaling within AML cells, but rather blocking the effect of AML blast PD-1H on T cell immune evasion. This evidence concerns the gene VSIR and acute myeloid leukemia.